ADC Therapeutics SA (ADCT)
4.70
+0.29
(+6.58%)
USD |
NYSE |
May 01, 16:00
4.70
0.00 (0.00%)
After-Hours: 19:59
ADC Therapeutics Debt to Equity Ratio: -0.7604 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.7604 |
| September 30, 2023 | -2.068 |
| June 30, 2023 | -12.95 |
| March 31, 2023 | 2.933 |
| December 31, 2022 | 1.381 |
| September 30, 2022 | 1.042 |
| June 30, 2022 | 0.8359 |
| March 31, 2022 | 0.5838 |
| December 31, 2021 | 0.7928 |
| September 30, 2021 | 0.4936 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.3724 |
| March 31, 2021 | 0.1321 |
| December 31, 2020 | 0.1145 |
| September 30, 2020 | 0.0969 |
| June 30, 2020 | 0.1832 |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | |
| June 30, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-12.95
Minimum
Jun 2023
2.933
Maximum
Mar 2023
-0.4009
Average
0.1832
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| Roche Holding AG | 0.9964 |
| AC Immune SA | 0.00 |
| CRISPR Therapeutics AG | 0.00 |
| Addex Therapeutics Ltd | 0.00 |
| NLS Pharmaceutics Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 354.78M |
| Total Liabilities (Quarterly) | 503.03M |
| Shareholders Equity (Quarterly) | -148.25M |
| Current Ratio | 4.970 |
| Net Debt Paydown Yield | -0.52% |